Načítá se...
VEGF(165) promotes the osteolytic bone destruction of Ewing's sarcoma tumors by upregulating RANKL
The purpose of this study was to determine whether vascular endothelial growth factor-165 (VEGF(165)) contributed to the osteolytic process in Ewing's sarcoma. VEGF(165) induced osteoclast formation from murine bone marrow cells. Tartrate-resistant acid phosphatase (TRAP) staining demonstrated...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2875875/ https://ncbi.nlm.nih.gov/pubmed/20066901 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|